Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens

被引:276
作者
Servin, AL [1 ]
Coconnier, MH [1 ]
机构
[1] INSERM, Unite 510, Fac Pharm Paris 11, F-92296 Chatenay Malabry, France
关键词
lactic acid bacteria; Lactobacillus; bifidobacteria; probiotic; pathogens; diarrhoea; gastrointestinal disease; antimicrobial;
D O I
10.1016/S1521-6918(03)00052-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Probiotic lactic acid strains are live micro-organisms that, when consumed in adequate amounts as part of food, confer a health benefit on the host. The scientific basis for the use of selected probiotic strains has only recently been firmly established, and appropriate and well-conducted experimental in vitro and in vivo studies, as well as clinical studies, are now beginning to be published, especially with regard to the effectiveness of probiotic strains in antagonizing pathogens. In particular, experimental data have allowed new insights into selected probiotic strains that express strain-specific probiotic properties and into the mechanism of action of these strains. The objective of this review is to analyse the in vitro or in vivo experimental studies in which the antimicrobial activity of selected Lactobacillus and Bifidobacterium strains has been documented.
引用
收藏
页码:741 / 754
页数:14
相关论文
共 119 条
[1]  
Aiba Y, 1998, AM J GASTROENTEROL, V93, P2097, DOI 10.1111/j.1572-0241.1998.00600.x
[2]   Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane [J].
Alakomi, HL ;
Skyttä, E ;
Saarela, M ;
Mattila-Sandholm, T ;
Latva-Kala, K ;
Helander, IM .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (05) :2001-2005
[3]   Recovery of Lactobacillus rhamnosus GG from human colonic biopsies [J].
Alander, M ;
Korpela, R ;
Saxelin, M ;
VilpponenSalmela, T ;
MattilaSandholm, T ;
vonWright, A .
LETTERS IN APPLIED MICROBIOLOGY, 1997, 24 (05) :361-364
[4]  
Alander M, 1999, APPL ENVIRON MICROB, V65, P351
[5]   Probiotic agents and infectious diseases: A modern perspective on a traditional therapy [J].
Alvarez-Olmos, MI ;
Oberhelman, RA .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (11) :1567-1576
[6]   INVITRO STUDIES ON THE INHIBITION OF THE GROWTH OF SHIGELLA-SONNEI BY LACTOBACILLUS-CASEI AND LACT-ACIDOPHILUS [J].
APELLA, MC ;
GONZALEZ, SN ;
DEMACIAS, MEN ;
ROMERO, N ;
OLIVER, G .
JOURNAL OF APPLIED BACTERIOLOGY, 1992, 73 (06) :480-483
[7]   Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides [J].
Asahara, T ;
Nomoto, K ;
Shimizu, K ;
Watanuki, M ;
Tanaka, R .
JOURNAL OF APPLIED MICROBIOLOGY, 2001, 91 (06) :985-996
[8]   LACTOBACILLUS-ACIDOPHILUS LA-1 BINDS TO CULTURED HUMAN INTESTINAL-CELL LINES AND INHIBITS CELL ATTACHMENT AND CELL INVASION BY ENTEROVIRULENT BACTERIA [J].
BERNET, MF ;
BRASSART, D ;
NEESER, JR ;
SERVIN, AL .
GUT, 1994, 35 (04) :483-489
[9]   ADHESION OF HUMAN BIFIDOBACTERIAL STRAINS TO CULTURED HUMAN INTESTINAL EPITHELIAL-CELLS AND INHIBITION OF ENTEROPATHOGEN-CELL INTERACTIONS [J].
BERNET, MF ;
BRASSART, D ;
NEESER, JR ;
SERVIN, AL .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1993, 59 (12) :4121-4128
[10]   The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo [J].
BernetCamard, MF ;
Lievin, V ;
Brassart, D ;
Neeser, JR ;
Servin, AL ;
Hudault, S .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1997, 63 (07) :2747-2753